Cargando…

Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy

BACKGROUND: The study evaluates the frequency of and indications for bone-metastases (BM)-related surgery and/or radiotherapy in the palliative breast cancer (BC) situation and analyzes in which phase of the palliative disease course surgery and/or radiotherapy was applied. METHODS: 340 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinauer, Kirsten, Huang, Dorothy Jane, Eppenberger-Castori, Serenella, Amann, Esther, Güth, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723608/
https://www.ncbi.nlm.nih.gov/pubmed/26909298
http://dx.doi.org/10.1016/j.jbo.2014.05.001
_version_ 1782411509389852672
author Steinauer, Kirsten
Huang, Dorothy Jane
Eppenberger-Castori, Serenella
Amann, Esther
Güth, Uwe
author_facet Steinauer, Kirsten
Huang, Dorothy Jane
Eppenberger-Castori, Serenella
Amann, Esther
Güth, Uwe
author_sort Steinauer, Kirsten
collection PubMed
description BACKGROUND: The study evaluates the frequency of and indications for bone-metastases (BM)-related surgery and/or radiotherapy in the palliative breast cancer (BC) situation and analyzes in which phase of the palliative disease course surgery and/or radiotherapy was applied. METHODS: 340 patients who developed distant metastatic disease (DMD) and died (i.e. patients with completed disease courses) were analyzed. RESULTS: From the entire study cohort, 237 patients (69.7%) were diagnosed with BM. Out of these, 116 patients (48.9%) received BM-related radiotherapy and/or surgery during the palliative situation. RADIOTHERAPY: 108 patients (45.6%) received 161 series (range: 1–5) with 217 volumina (range: 1–8) on 300 osseous sites. At 75.3% of the radiated sites, the spine was the most frequent radiated location. Eighty-eight series (54.7%) were performed in the first third of the metastatic disease survival (MDS) period. The median survival after radiotherapy was 14 months (range: 0.2–121 months). SURGERY: In 37 patients (15.6%), 50 procedures (range: 1–4) were necessary to stabilize BM. The femur predominated with 56.0% of the procedures. Twenty procedures (40.0%) were performed in the first third of survival follow-up. The median survival after surgery was 13.5 months (range: 0.5–49 months). BC patients with BM had a significantly improved MDS when radiotherapy and/or surgery for skeletal metastases was embedded in the palliative approach (27.5 months vs. 19.5 months, p<0.001). From the 118 patients who had a MDS of ≥24 months, the majority (54.2%) had BM-related radiotherapy and/or surgery during the palliative course. CONCLUSIONS: Metastatic BC has become increasingly viewed as a chronic disease process. In a general palliative therapy approach, which allows for treatment according to the principles of a chronic disease, non-systemic therapy for BM, in particular radiotherapy, has a clearly established role in the therapy concept.
format Online
Article
Text
id pubmed-4723608
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47236082016-02-23 Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy Steinauer, Kirsten Huang, Dorothy Jane Eppenberger-Castori, Serenella Amann, Esther Güth, Uwe J Bone Oncol Research Article BACKGROUND: The study evaluates the frequency of and indications for bone-metastases (BM)-related surgery and/or radiotherapy in the palliative breast cancer (BC) situation and analyzes in which phase of the palliative disease course surgery and/or radiotherapy was applied. METHODS: 340 patients who developed distant metastatic disease (DMD) and died (i.e. patients with completed disease courses) were analyzed. RESULTS: From the entire study cohort, 237 patients (69.7%) were diagnosed with BM. Out of these, 116 patients (48.9%) received BM-related radiotherapy and/or surgery during the palliative situation. RADIOTHERAPY: 108 patients (45.6%) received 161 series (range: 1–5) with 217 volumina (range: 1–8) on 300 osseous sites. At 75.3% of the radiated sites, the spine was the most frequent radiated location. Eighty-eight series (54.7%) were performed in the first third of the metastatic disease survival (MDS) period. The median survival after radiotherapy was 14 months (range: 0.2–121 months). SURGERY: In 37 patients (15.6%), 50 procedures (range: 1–4) were necessary to stabilize BM. The femur predominated with 56.0% of the procedures. Twenty procedures (40.0%) were performed in the first third of survival follow-up. The median survival after surgery was 13.5 months (range: 0.5–49 months). BC patients with BM had a significantly improved MDS when radiotherapy and/or surgery for skeletal metastases was embedded in the palliative approach (27.5 months vs. 19.5 months, p<0.001). From the 118 patients who had a MDS of ≥24 months, the majority (54.2%) had BM-related radiotherapy and/or surgery during the palliative course. CONCLUSIONS: Metastatic BC has become increasingly viewed as a chronic disease process. In a general palliative therapy approach, which allows for treatment according to the principles of a chronic disease, non-systemic therapy for BM, in particular radiotherapy, has a clearly established role in the therapy concept. Elsevier 2014-05-20 /pmc/articles/PMC4723608/ /pubmed/26909298 http://dx.doi.org/10.1016/j.jbo.2014.05.001 Text en © 2014 Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Steinauer, Kirsten
Huang, Dorothy Jane
Eppenberger-Castori, Serenella
Amann, Esther
Güth, Uwe
Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title_full Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title_fullStr Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title_full_unstemmed Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title_short Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
title_sort bone metastases in breast cancer: frequency, metastatic pattern and non-systemic locoregional therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723608/
https://www.ncbi.nlm.nih.gov/pubmed/26909298
http://dx.doi.org/10.1016/j.jbo.2014.05.001
work_keys_str_mv AT steinauerkirsten bonemetastasesinbreastcancerfrequencymetastaticpatternandnonsystemiclocoregionaltherapy
AT huangdorothyjane bonemetastasesinbreastcancerfrequencymetastaticpatternandnonsystemiclocoregionaltherapy
AT eppenbergercastoriserenella bonemetastasesinbreastcancerfrequencymetastaticpatternandnonsystemiclocoregionaltherapy
AT amannesther bonemetastasesinbreastcancerfrequencymetastaticpatternandnonsystemiclocoregionaltherapy
AT guthuwe bonemetastasesinbreastcancerfrequencymetastaticpatternandnonsystemiclocoregionaltherapy